G4A provides digital health tech startups with a gateway to accessing digital health partnerships with Bayer Pharma. We develop relationships with each startup, and tailor our partnership to their needs–providing resources, expertise, and connections to amplify and accelerate their business without giving up equity as a requirement.
As technology improves and becomes more accessible to more people, digital health will be the new foundation of healthcare across the entire system. G4A is participating in and enabling that transformation.
Why should you be interested in the Growth Track?
We provide you with the financing you need to take off
Our Growth Track startups gain a EUR 25,000 to EUR 100,000 convertible loan.
Mentorship by industry experts
Growth Track Startups receive personalised mentorship, by Bayer executives and external industry experts. Individualised coaching ensures Startups enter the healthcare market successfully.
Cardiovascular diseases cause 31% of all global deaths1. Behavioral risk factors including unhealthy diet, physical inactivity, tobacco use, and harmful use of alcohol can contribute to the onset and progression of cardiovascular disease.
We are looking for companies that are developing behavior change solutions which reduce the progression of cardio-metabolic conditions (such as hypertension, chronic artery disease, etc.)
We are looking for companies that are developing behavior change solutions addressing specifically the risk factors of cardio-metabolic conditions. For example, solutions which address and improve sleep health, improve mental health or support smoking cessation.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: US, Germany, France, UK, China
Digital tools increasingly allow for remote monitoring of patients and generation of data which can be utilized for early identification of disease risk through novel biomarkers. These can help with timely diagnosis and improved treatment of cardio-metabolic conditions.
We are looking for solutions which would allow a convenient and effortless way to monitor patients, track their disease progression and effectiveness of treatment as well as support early diagnosis of related conditions.
We are also looking for companies developing novel biomarkers (digital, biological or in combination) and algorithms to predict the risk, progression or start of acute events in cardiovascular and renal diseases.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: US, Germany, France, UK, China
Evidence shows that social isolation and loneliness are associated with negative cardiovascular outcomes 2. Social or community support can also lead to increased participation in physical activity 3 leading to improved health outcomes.
We are looking for solutions that would help individuals with or at risk of cardio-metabolic conditions to access, engage with and benefit from strong social support solutions.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: US, Germany, France, UK, China
Screening/Diagnosis and Improvement of Bone Health
80% of people affected by osteoporosis are women and, in the US, approximately 1 in 2 women over the age of 50 will break a bone due to osteoporosis4. As women go through menopause, the risk of osteoporosis increases3.
We are looking for digital solutions that can help women prevent bone deterioration and improve their bone health.
In addition, we are also looking for digital solutions that can assess risk and/ or help early screening for diagnosis of osteoporosis.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: Primary US, Secondary Europe
1 in 10 women are affected by Polycystic Ovary Syndrome (PCOS), a complex syndrome with multiple symptoms and risk of other health problems1. Similarly, up to 15% of women of childbearing age worldwide are affected by Endometriosis, a chronic and often debilitating condition 2. Both, PCOS and Endometriosis, can go undiagnosed for years, leading to delayed recognition and management of the condition.
We are looking for digital health solutions which can help with early screening and/or diagnosis of PCOS and Endometriosis.
Open to both Growth and Advanced Tracks
Geographical Region Scalability: Primary US, Secondary Europe
Mental health conditions cause 1 in 5 years lived with disability1. It is estimated that nearly one-third of people diagnosed with a serious, life-changing chronic illness (i.e. heart disease, cancer, diabetes) or disease will experience symptoms of depression and anxiety.2
We are looking for digital health solutions and platforms which help people manage and improve their mental health and wellness .
Growth Track Startups receive personalised mentorship, by Bayer executives and external industry experts. Individualised coaching ensures Startups enter the healthcare market successfully.
Can’t see anything that your solution is suitable for?
Check out our regular event series “Pitch Club” which provides a stage to extraordinary digital health startups